American Well Co. (NYSE:AMWL) EVP Sells $24,719.67 in Stock

American Well Co. (NYSE:AMWL) EVP Vukasin Paunovich sold 3,141 shares of the stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $7.87, for a total transaction of $24,719.67. Following the completion of the transaction, the executive vice president now owns 120,176 shares of the company’s stock, valued at $945,785.12. The sale was disclosed in a document filed with the SEC, which is available through this link.

Vukasin Paunovich also recently made the following trade(s):

• On Monday, July 1st, Vukasin Paunovich sold 397 shares of American Well stock. The stock was sold at an average price of $6.00, for a total transaction of $2,382.00.

American Well Trading Up 2.7 %

NYSE:AMWL traded up $0.21 on Thursday, reaching $8.00. 35,145 shares of the stock traded hands, compared to its average volume of 125,169. The company has a market capitalization of $118.58 million, a price-to-earnings ratio of -0.33 and a beta of 1.04. American Well Co. has a 12 month low of $5.00 and a 12 month high of $31.60. The company’s fifty day simple moving average is $8.10 and its 200 day simple moving average is $11.41.

American Well (NYSE:AMWL) last announced its quarterly earnings results on Wednesday, July 31st. The company reported ($3.36) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($3.94) by $0.58. The firm had revenue of $62.79 million for the quarter, compared to the consensus estimate of $60.78 million. American Well had a negative net margin of 120.44% and a negative return on equity of 50.36%. During the same quarter last year, the firm posted ($4.60) EPS. Equities analysts anticipate that American Well Co. will post -13.91 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on AMWL. Wells Fargo & Company decreased their price target on shares of American Well from $40.00 to $15.00 and set an “equal weight” rating for the company in a research note on Tuesday, August 6th. UBS Group reduced their price objective on shares of American Well from $30.00 to $12.00 and set a “neutral” rating for the company in a research note on Thursday, May 23rd. Finally, Needham & Company LLC restated a “hold” rating on shares of American Well in a research note on Thursday, August 1st.

Institutional Trading of American Well

A number of institutional investors have recently made changes to their positions in the stock. Rock Point Advisors LLC boosted its holdings in shares of American Well by 1.9% during the 2nd quarter. Rock Point Advisors LLC now owns 2,308,617 shares of the company’s stock valued at $750,000 after acquiring an additional 43,500 shares during the last quarter. Oak Thistle LLC purchased a new stake in shares of American Well during the 1st quarter valued at about $46,000. RPO LLC purchased a new stake in shares of American Well during the 4th quarter valued at about $85,000. Point72 DIFC Ltd boosted its holdings in shares of American Well by 1,418.5% during the 2nd quarter. Point72 DIFC Ltd now owns 103,457 shares of the company’s stock valued at $34,000 after acquiring an additional 96,644 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of American Well by 75.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 289,318 shares of the company’s stock valued at $235,000 after acquiring an additional 124,441 shares during the last quarter. Hedge funds and other institutional investors own 56.05% of the company’s stock.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.